Connable Office Inc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Connable Office Inc’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-56,053	Closed	-$1.76M	–	207
2022 Q2	$1.76M	Buy	+56,053	New	+$1.96M	0.27%	68
2022 Q1	–	Sell	-35,473	Closed	-$2.17M	–	216
2021 Q4	$2.17M	Buy	+35,473	New	+$2.45M	0.28%	74

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Connable Office Inc's ARKG Position: Q3 2022 in Review

Connable Office Inc sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 56,053 shares — an estimated $1.76M sold.

Connable Office Inc first reported a position in ARKG in Q4 2021 and held it in 2 quarters. The position peaked at $2.17M in Q4 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

Connable Office Inc reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
Connable Office Inc sold 56,053 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $1.76M.
Connable Office Inc first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 2 quarters.
Connable Office Inc's ARK Genomic Revolution ETF position peaked at $2.17M in Q4 2021.
311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Connable Office Inc's 13F filing for Q3 2022, filed 26 Oct 2022.